Glenmark Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

11 Aug 2020 | 04:14 PM

477.05
5.75 (1.22%)

  • Outperforms Index

    11.93%

    Return (1Y)

    Beaten Nifty 200 by 8.15%

  • More Volatile

    4.09%

    Standard Deviation (1Y)

    Higher than Nifty 200 by 2.17%

  • Not so consistent

    6/12

    Months

    underperformed Nifty 200

  • AxisDirect View

    No View

52 Week High-Low

573

573.05

162

161.65

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Glenmark Pharmaceuticals Ltd has decreased by -17.93% since past 3 Months

  • MF shareholding in Glenmark Pharmaceuticals Ltd has decreased by -37.1% since past 3 Months

  • FII shareholding in Glenmark Pharmaceuticals Ltd has decreased by -24.61% since past 1 Year

  • MF shareholding in Glenmark Pharmaceuticals Ltd has decreased by -51.7% since past 1 Year

Loading...